Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA590477
Max Phase: Preclinical
Molecular Formula: C28H29F3N4O5S2
Molecular Weight: 622.69
Molecule Type: Small molecule
Associated Items:
ID: ALA590477
Max Phase: Preclinical
Molecular Formula: C28H29F3N4O5S2
Molecular Weight: 622.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccc(N2CCCC2)nc1)N1CCC(NS(=O)(=O)c2cc(S(=O)(=O)c3ccccc3)ccc2C(F)(F)F)CC1
Standard InChI: InChI=1S/C28H29F3N4O5S2/c29-28(30,31)24-10-9-23(41(37,38)22-6-2-1-3-7-22)18-25(24)42(39,40)33-21-12-16-35(17-13-21)27(36)20-8-11-26(32-19-20)34-14-4-5-15-34/h1-3,6-11,18-19,21,33H,4-5,12-17H2
Standard InChI Key: BJYVJTMJQKDWCY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 622.69 | Molecular Weight (Monoisotopic): 622.1531 | AlogP: 4.12 | #Rotatable Bonds: 7 |
Polar Surface Area: 116.75 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.43 | CX Basic pKa: 4.87 | CX LogP: 3.63 | CX LogD: 3.60 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.42 | Np Likeness Score: -1.98 |
1. Moore WJ, Kern JC, Bhat R, Bodine PV, Fukyama S, Krishnamurthy G, Magolda RL, Pitts K, Stauffer B, Trybulski EJ.. (2010) Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: part II., 18 (1): [PMID:19932972] [10.1016/j.bmc.2009.11.002] |
Source(1):